Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles A Day

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Current Protocols|January 14, 2026
Analysis of Protein and Lipid Dynamics Using Confocal Fluorescence Recovery After PhotobleachingCharles A Day, Lewis J Kraft, Minchul Kang, et al.
Current Protocols in Cytometry|October 9, 2012
Analysis of protein and lipid dynamics using confocal fluorescence recovery after photobleaching (FRAP)Charles A Day, Lewis J Kraft, Minchul Kang, et al.
Sub-Cellular Biochemistry|July 7, 2007
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAidsR Preston Mason, Mary F Walter, Charles A Day, et al.
Biophysical Journal|September 2, 2009
A generalization of theory for two-dimensional fluorescence recovery after photobleaching applicable to confocal laser scanning microscopesMinchul Kang, Charles A Day, Kimberly Drake, et al.
The American Journal of Cardiology|August 30, 2005
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actionsR Preston Mason, Mary F Walter, Charles A Day, et al.
Methods in Cell Biology|June 30, 2018
Microsurgery and microinjection techniques in mitosis researchCharles A Day, Jessica Hornick, Alyssa Langfald, et al.
The Journal of Biological Chemistry|February 9, 2006
Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanismR Preston Mason, Mary F Walter, Charles A Day, et al.
Atherosclerosis|November 9, 2004
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDsMary F Walter, Robert F Jacob, Charles A Day, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Commitment to cytokinetic furrowing requires the coordinate activity of microtubules and Plk1Charles A Day, Alyssa Langfald, Tana Lukes, et al.
Biochemistry|February 10, 2016
Topologically Diverse Human Membrane Proteins Partition to Liquid-Disordered Domains in Phase-Separated Lipid VesiclesJonathan P Schlebach, Paul J Barrett, Charles A Day, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Current Protocols|January 14, 2026
Analysis of Protein and Lipid Dynamics Using Confocal Fluorescence Recovery After PhotobleachingCharles A Day, Lewis J Kraft, Minchul Kang, et al.
Current Protocols in Cytometry|October 9, 2012
Analysis of protein and lipid dynamics using confocal fluorescence recovery after photobleaching (FRAP)Charles A Day, Lewis J Kraft, Minchul Kang, et al.
Sub-Cellular Biochemistry|July 7, 2007
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAidsR Preston Mason, Mary F Walter, Charles A Day, et al.
Biophysical Journal|September 2, 2009
A generalization of theory for two-dimensional fluorescence recovery after photobleaching applicable to confocal laser scanning microscopesMinchul Kang, Charles A Day, Kimberly Drake, et al.
The American Journal of Cardiology|August 30, 2005
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actionsR Preston Mason, Mary F Walter, Charles A Day, et al.
Methods in Cell Biology|June 30, 2018
Microsurgery and microinjection techniques in mitosis researchCharles A Day, Jessica Hornick, Alyssa Langfald, et al.
The Journal of Biological Chemistry|February 9, 2006
Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanismR Preston Mason, Mary F Walter, Charles A Day, et al.
Atherosclerosis|November 9, 2004
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDsMary F Walter, Robert F Jacob, Charles A Day, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Commitment to cytokinetic furrowing requires the coordinate activity of microtubules and Plk1Charles A Day, Alyssa Langfald, Tana Lukes, et al.
Biochemistry|February 10, 2016
Topologically Diverse Human Membrane Proteins Partition to Liquid-Disordered Domains in Phase-Separated Lipid VesiclesJonathan P Schlebach, Paul J Barrett, Charles A Day, et al.
Pageof 3